Clinical Trial Update: Human Umbilical Cord Mesenchymal Stem Cell in Cerebral Hemorrhage Sequela [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating human umbilical cord mesenchymal stem cells for sequelae of cerebral hemorrhage. The current trial status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebral Hemorrhage

Drugs mentioned

• Human Umbilical Cord Mesenchymal Stem Cells

Snippet

Sponsor: Shenzhen Hornetcorn Bio-technology Company, LTD | Conditions: Cerebral Hemorrhage | Phase 1 | Status: UNKNOWN